Modulation of heme oxygenase-1 expression and activity affects streptozotocin-induced diabetic nephropathy in rats

Marwa A.M. Ali, Gehan H. Heeba, Azza A.K. El-Sheikh

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Abstract

Heme oxygenase (HO)-1 has exhibited nephro-protective actions in different animal models; however, its full mechanistic potential in diabetic nephropathy (DN) has not yet been elucidated. Hence, the present study has been undertaken by inducing DN in rats using streptozotocin (50 mg/kg i.p.), with or without either HO-1 inducer; hemin (HM; 40 μmol/kg, s.c.), or HO-1 blocker; zinc protoporphyrin-IX (ZnPP; 50 μmol/kg, i.p.), for one month. Compared to control, rats with DN suffered from hyperglycemia and hyperlipidemia, with signs of renal damage, as assessed by distortion in renal histopathologic architecture and kidney function. Renal oxidative/nitrosative stress was evident by increased malondialdehyde, nitric oxide, myeloperoxidase, with decreased reduced glutathione, superoxide dismutase, and catalase. DN group also exhibited high renal expression of the pro-inflammatory cytokine; tumor necrosis factor (TNF)-α, and the apoptotic marker; caspase 3, assessed by Western blot. Renal HO-1 protein expression and activity were increased in DN rats compared to control. Administration of HM, but not ZnPP, to DN rats improved kidney function, histopathologic features, lipid profile, TNF-α, and caspase 3 expressions, with no effect on blood glucose level. HM increased, while ZnPP decreased renal HO-1 activity in DN rats. It is noteworthy that neither intervention affected HO-1 activity or renal oxidative capacity in non-diabetic rats. Interestingly, the expression of HO-1 was upregulated by both HM and ZnPP in DN rats. In conclusion, activation of HO-1 via HM ameliorated renal damage in STZ-induced DN in rats, probably through antioxidant, anti-nitrosative, anti-inflammatory, and anti-apoptotic mechanisms.

Original languageEnglish
Pages (from-to)546-557
Number of pages12
JournalFundamental and Clinical Pharmacology
Volume31
Issue number5
DOIs
Publication statusPublished - 1 Oct 2017

Fingerprint

Heme Oxygenase-1
Diabetic Nephropathies
Streptozocin
Kidney
Caspase 3
Tumor Necrosis Factor-alpha
Hemin
Hyperlipidemias
Malondialdehyde
Hyperglycemia
Catalase
Peroxidase
Superoxide Dismutase
Glutathione
Blood Glucose
Nitric Oxide
Oxidative Stress
Anti-Inflammatory Agents
Animal Models
Antioxidants

Keywords

  • caspase 3
  • diabetic nephropathy
  • heme oxygenase-1
  • hemin
  • oxidative stress
  • TNF-α
  • zinc protoporphyrin-IX

Cite this

@article{a38ea5009f2746a0ae48ca3157bf2f64,
title = "Modulation of heme oxygenase-1 expression and activity affects streptozotocin-induced diabetic nephropathy in rats",
abstract = "Heme oxygenase (HO)-1 has exhibited nephro-protective actions in different animal models; however, its full mechanistic potential in diabetic nephropathy (DN) has not yet been elucidated. Hence, the present study has been undertaken by inducing DN in rats using streptozotocin (50 mg/kg i.p.), with or without either HO-1 inducer; hemin (HM; 40 μmol/kg, s.c.), or HO-1 blocker; zinc protoporphyrin-IX (ZnPP; 50 μmol/kg, i.p.), for one month. Compared to control, rats with DN suffered from hyperglycemia and hyperlipidemia, with signs of renal damage, as assessed by distortion in renal histopathologic architecture and kidney function. Renal oxidative/nitrosative stress was evident by increased malondialdehyde, nitric oxide, myeloperoxidase, with decreased reduced glutathione, superoxide dismutase, and catalase. DN group also exhibited high renal expression of the pro-inflammatory cytokine; tumor necrosis factor (TNF)-α, and the apoptotic marker; caspase 3, assessed by Western blot. Renal HO-1 protein expression and activity were increased in DN rats compared to control. Administration of HM, but not ZnPP, to DN rats improved kidney function, histopathologic features, lipid profile, TNF-α, and caspase 3 expressions, with no effect on blood glucose level. HM increased, while ZnPP decreased renal HO-1 activity in DN rats. It is noteworthy that neither intervention affected HO-1 activity or renal oxidative capacity in non-diabetic rats. Interestingly, the expression of HO-1 was upregulated by both HM and ZnPP in DN rats. In conclusion, activation of HO-1 via HM ameliorated renal damage in STZ-induced DN in rats, probably through antioxidant, anti-nitrosative, anti-inflammatory, and anti-apoptotic mechanisms.",
keywords = "caspase 3, diabetic nephropathy, heme oxygenase-1, hemin, oxidative stress, TNF-α, zinc protoporphyrin-IX",
author = "Ali, {Marwa A.M.} and Heeba, {Gehan H.} and El-Sheikh, {Azza A.K.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1111/fcp.12296",
language = "English",
volume = "31",
pages = "546--557",
journal = "Fundamental and Clinical Pharmacology",
issn = "0767-3981",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "5",

}

Modulation of heme oxygenase-1 expression and activity affects streptozotocin-induced diabetic nephropathy in rats. / Ali, Marwa A.M.; Heeba, Gehan H.; El-Sheikh, Azza A.K.

In: Fundamental and Clinical Pharmacology, Vol. 31, No. 5, 01.10.2017, p. 546-557.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Modulation of heme oxygenase-1 expression and activity affects streptozotocin-induced diabetic nephropathy in rats

AU - Ali, Marwa A.M.

AU - Heeba, Gehan H.

AU - El-Sheikh, Azza A.K.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Heme oxygenase (HO)-1 has exhibited nephro-protective actions in different animal models; however, its full mechanistic potential in diabetic nephropathy (DN) has not yet been elucidated. Hence, the present study has been undertaken by inducing DN in rats using streptozotocin (50 mg/kg i.p.), with or without either HO-1 inducer; hemin (HM; 40 μmol/kg, s.c.), or HO-1 blocker; zinc protoporphyrin-IX (ZnPP; 50 μmol/kg, i.p.), for one month. Compared to control, rats with DN suffered from hyperglycemia and hyperlipidemia, with signs of renal damage, as assessed by distortion in renal histopathologic architecture and kidney function. Renal oxidative/nitrosative stress was evident by increased malondialdehyde, nitric oxide, myeloperoxidase, with decreased reduced glutathione, superoxide dismutase, and catalase. DN group also exhibited high renal expression of the pro-inflammatory cytokine; tumor necrosis factor (TNF)-α, and the apoptotic marker; caspase 3, assessed by Western blot. Renal HO-1 protein expression and activity were increased in DN rats compared to control. Administration of HM, but not ZnPP, to DN rats improved kidney function, histopathologic features, lipid profile, TNF-α, and caspase 3 expressions, with no effect on blood glucose level. HM increased, while ZnPP decreased renal HO-1 activity in DN rats. It is noteworthy that neither intervention affected HO-1 activity or renal oxidative capacity in non-diabetic rats. Interestingly, the expression of HO-1 was upregulated by both HM and ZnPP in DN rats. In conclusion, activation of HO-1 via HM ameliorated renal damage in STZ-induced DN in rats, probably through antioxidant, anti-nitrosative, anti-inflammatory, and anti-apoptotic mechanisms.

AB - Heme oxygenase (HO)-1 has exhibited nephro-protective actions in different animal models; however, its full mechanistic potential in diabetic nephropathy (DN) has not yet been elucidated. Hence, the present study has been undertaken by inducing DN in rats using streptozotocin (50 mg/kg i.p.), with or without either HO-1 inducer; hemin (HM; 40 μmol/kg, s.c.), or HO-1 blocker; zinc protoporphyrin-IX (ZnPP; 50 μmol/kg, i.p.), for one month. Compared to control, rats with DN suffered from hyperglycemia and hyperlipidemia, with signs of renal damage, as assessed by distortion in renal histopathologic architecture and kidney function. Renal oxidative/nitrosative stress was evident by increased malondialdehyde, nitric oxide, myeloperoxidase, with decreased reduced glutathione, superoxide dismutase, and catalase. DN group also exhibited high renal expression of the pro-inflammatory cytokine; tumor necrosis factor (TNF)-α, and the apoptotic marker; caspase 3, assessed by Western blot. Renal HO-1 protein expression and activity were increased in DN rats compared to control. Administration of HM, but not ZnPP, to DN rats improved kidney function, histopathologic features, lipid profile, TNF-α, and caspase 3 expressions, with no effect on blood glucose level. HM increased, while ZnPP decreased renal HO-1 activity in DN rats. It is noteworthy that neither intervention affected HO-1 activity or renal oxidative capacity in non-diabetic rats. Interestingly, the expression of HO-1 was upregulated by both HM and ZnPP in DN rats. In conclusion, activation of HO-1 via HM ameliorated renal damage in STZ-induced DN in rats, probably through antioxidant, anti-nitrosative, anti-inflammatory, and anti-apoptotic mechanisms.

KW - caspase 3

KW - diabetic nephropathy

KW - heme oxygenase-1

KW - hemin

KW - oxidative stress

KW - TNF-α

KW - zinc protoporphyrin-IX

UR - http://www.scopus.com/inward/record.url?scp=85021405490&partnerID=8YFLogxK

U2 - 10.1111/fcp.12296

DO - 10.1111/fcp.12296

M3 - Article

VL - 31

SP - 546

EP - 557

JO - Fundamental and Clinical Pharmacology

JF - Fundamental and Clinical Pharmacology

SN - 0767-3981

IS - 5

ER -